Navigation Links
Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient
Date:1/11/2008

$110,000,000.00 lawsuit filed 11 Dec. 2008

ATLANTA, Jan. 11 /PRNewswire-USNewswire/ -- Cryolife, Inc., (NYSE: CRY) the country's largest distributor of cadaver tissue has once again severely maimed an elective knee surgery patient, Michael Hohenbery, with a contaminated infected knee tissue implant. Shockingly the same deadly organism that devastated Mr. Hohenbery took the life of young Brian Lykins of Minnesota in 2001.

The Lykins' death, another of the Keenan Law Firm's clients, first alerted the nation of the unregulated cadaver tissue billion dollar industry. Brian's death led the FDA shutdown in 2002 of Cryolife's tissue business and the passage of 900 plus pages of safety regulations which at the time of passage were insufficient and created large loopholes.

The FDA eventually after a year in mid 2003 permitted Cryolife to resume distribution of cadaver tissue but yet less than 30 days later a teenager from Denver was catastrophically infected by diseased knee cadaver tissue. Over the years many lawsuits have been prosecuted across the United Stated, Europe, and other countries concerning unsafe cadaver processing practices.

The recent victim Michael Hohenbery a farm equipment mechanic from downstate Illinois can no longer work and will be on mega antibiotics and pain medications the rest of his life. His suit will be filed Friday in Cobb County the location of Cryolife.

The Hohenbery case once again proves the unsafe and dangerous practices of Cryolife and the ineffectiveness of the safety regulations. While all states require licensure, testing and health certificates for barbers, nail salon technicians, and masseuses, there are no regulations regarding the qualifications of anyone handling and processing cadaver tissue.

"With over one million operations a year using cadaver tissues, how many more people will die or be seriously injured from dangerous unsafe practices of Cryolife. This travesty must stop," said Don Keenan attorney for Michael Hohenbery.

Don Keenan is available for comment 24/7.


'/>"/>
SOURCE KEENAN LAW FIRM/KEENAN'S KIDS FOUNDATION
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Names Philip Theodore as Vice President, General Counsel
2. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
5. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
6. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
7. CryoLife to Present at OneMedPlace Finance Forum
8. CryoLife Announces Record Preservation Services and Product Revenues for 2007
9. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
10. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from non-small cell ... with limited tumor content in a large background of normal or wild type ... need for reliable detection of low abundance somatic mutations, particularly in small specimens ...
(Date:3/27/2017)...  Perthera,s Chief Bioinformatics Officer and research faculty member ... Ph.D., will be speaking at the American Medical Informatics ... 27, 2017, she will be speaking on the topic ... and Care" (from 10:30 a.m. – 12:00 p.m. PST) ... a participant in the "Making Precision Oncology Data More ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... to engineer scalable and customizable vascular grafts in JoVE’s Video Journal, the world’s ... to new and improved ways of treating coronary artery disease (CAD). Lam is ...
(Date:3/27/2017)... , March 27, 2017 Neurotrope, ... novel therapies for neurodegenerative diseases, including Alzheimer,s disease, ... its application to list the Company,s common stock ... by The NASDAQ Stock Market, a unit of ... listing, Neurotrope will ring the Opening Bell at the ...
Breaking Biology Technology:
(Date:2/21/2017)... Ore. , Feb. 22, 2017  IBM (NYSE: ... (Avamere Health Services, Infinity Rehab, Signature Hospice, Home Health, ... will apply the power of IBM cognitive computing to ... centers. By analyzing data streaming from sensors in senior ... and environmental conditions, and obtain deeper learnings into the ...
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):